Actinogen Medical’s Xanamem shows meaningful antidepressant activity in Phase 2 trial - Proactive Investors

Submitted by Anonymous (not verified) on Fri, 07/24/2026 - 00:37

Actinogen Medical’s Xanamem shows meaningful antidepressant activity in Phase 2 trial  Proactive Investors